DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06998 GENOR-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Hillhouse Investment Management, Ltd. (24.23%)
Yunnan Walvax Biotechnology Co., Ltd. (7.11%)
Temasek Holdings (Private) Limited (5.90%)		 Sector Health Care & Biotechnology
Web Site http://www.genorbio.com Tel (86 21) 6169-0700
Email ir@genorbio.com Fax N/A
Related Equities N/A
Principal Activities Principally focus on developing and commercializing oncology and autoimmune drugs in the People's Republic of China.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top